Sarepta’s Medical Director, Clinical Development discusses the company’s upcoming ENVISION study for SRP-9001. Research & Clinical Trial Webinars,Webinars 1 year ago You may also like 52:31 Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO 10 months ago Research & Clinical Trial Webinars,Webinars 31:23 Advocating for Access: Insurance 101 10 months ago Care Webinars,Webinars 29:12 Advocating for Access: Navigating Approved Therapies in Duchenne 11 months ago Care Webinars,Webinars 1:11:00 Webinar: ELEVIDYS Approval: What this means for you and your family 1 year ago Care Webinars,Webinars 37:54 Community Town Hall: SRP-9001 Advisory Committee Update (May 2023) 1 year ago Research & Clinical Trial Webinars,Webinars 55:52 Webinar: Edgewise — A Novel Approach Designed to Protect Muscle in Becker (May 2023) 1 year ago Research & Clinical Trial Webinars,Webinars 48:49 Webinar: Dyne Therapeutics — Advancing FORCE in the Pursuit of Therapies (April 2023) 1 year ago Research & Clinical Trial Webinars,Webinars 1:01:16 Connect With the Experts: Bone Health in Duchenne (April 2023) 1 year ago Care Webinars,Webinars «12345…24»Page 3 of 24